Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

BACKGROUND: Platinum and fluoropyrimidine combinations typically comprise first‐line (1L) therapy in advanced gastric cancer or gastroesophageal junction adenocarcinoma (G/GEA), although controversy exists regarding the use of 5doublet versus triplet cytotoxic regimens. Historically, second‐line (2L...

Descripción completa

Detalles Bibliográficos
Autores principales: Catenacci, Daniel V., Chao, Joseph, Muro, Kei, Al‐Batran, Salah Eddin, Klempner, Samuel J., Wainberg, Zev A., Shah, Manish A., Rha, Sun Young, Ohtsu, Atsushi, Liepa, Astra M., Knoderer, Holly, Chatterjee, Anindya, Van Cutsem, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488781/
https://www.ncbi.nlm.nih.gov/pubmed/34288262
http://dx.doi.org/10.1002/onco.13907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488781/
https://www.ncbi.nlm.nih.gov/pubmed/34288262
http://dx.doi.org/10.1002/onco.13907

Ejemplares similares